| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |